Copyright
        ©The Author(s) 2024.
    
    
        World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2816-2825
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2816
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2816
            Table 1 Basic characteristics of included studies and Newcastle-Ottawa Scale scores (mean ± SD)
        
    | Ref. | Time | Research type | Cases | Gender (male/female) | Age (yr) | Stage | Follow-up time (months) | NOS score | 
| Ueno et al[5] | 2002 | Cohort study | 627 | 393/234 | 60.3 ± 12 | Ⅰ-Ⅲ | 153 (80-267) | 6 | 
| Ueno et al[6] | 2004 | Cohort study | 862 | NA | NA | Ⅰ-Ⅲ | 140 | 6 | 
| Wu et al[7] | 2014 | Cohort study | 412 | NA | 61.4 ± 12 | Ⅳ | 61 (11-188) | 7 | 
| Ueno et al[8] | 2015 | Cohort study | 880 | 512/368 | 62.9 ± 13 | Ⅱ-Ⅲ | 68 | 8 | 
| Ueno et al[8] | 2015 | Cohort study | 474 | 268/206 | 66.3 ± 13 | Ⅱ-Ⅲ | 68 | 6 | 
| Ueno et al[9] | 2017 | Cohort study | 821 | 484/337 | 66.2 ± 12 | Ⅱ-Ⅲ | 59 (1-86) | 7 | 
| Wu et al[10] | 2018 | Cohort study | 466 | 264/202 | 59.9 ± 13 | Ⅲ | 59 (45-144) | 7 | 
| Wu et al[10] | 2018 | Cohort study | 432 | 247/185 | 65.1 ± 12 | Ⅲ | 58 (1-87) | 8 | 
| Shin et al[11] | 2019 | Cohort study | 151 | 88/63 | 63.2 ± 11 | Ⅰ-Ⅳ | 56 | 6 | 
| Konishi et al[12] | 2018 | Cohort study | 851 | 407/444 | 66 ± 14 | Ⅰ-Ⅲ | 58 | 6 | 
| Nearchou et al[13] | 2019 | Cohort study | 283 | 184/99 | 62.3 ± 11 | Ⅱ | NA | 6 | 
| Nearchou et al[13] | 2019 | Cohort study | 163 | 87/76 | 63 ± 12 | Ⅱ | NA | 7 | 
| Ueno et al[14] | 2019 | Cohort study | 679 | 400/279 | 64.0 ± 12 | Ⅱ | 91 | 8 | 
| Ueno et al[14] | 2019 | Cohort study | 446 | 267/179 | 67.0 ± 12 | Ⅱ | 58 | 8 | 
| González et al[15] | 2020 | Cohort study | 342 | 179/163 | 65.2 ± 12.6 | Ⅰ-Ⅲ | NA | 8 | 
| Hacking et al[16] | 2020 | Cohort study | 234 | 111/118 | 64 ± 13 | I-Ⅲ | NA | 6 | 
| Ao et al[17] | 2020 | Cohort study | 363 | 209/154 | 66.6 ± 12 | Ⅲ | 61 (1-136) | 8 | 
| Gonzalez et al[18] | 2021 | Cohort study | 372 | 189/183 | 65.7 ± 12.9 | Ⅰ-Ⅲ | 62 (1-170) | 6 | 
| Ueno et al[19] | 2021 | Cohort study | 991 | 601/390 | 65.5 ± 12.2 | Ⅱ | 69.7 (2.1-105.6) | 7 | 
            Table 2 Meta-regression analysis of recurrence survival and overall survival
        
    | Interstitial maturity | Heterogeneous factor | Relapse free survival | Overall survival rate | ||
| Coefficient | P value | Coefficient | P value | ||
| Immaturity | Age | 0.098 | 0.8 | 0.06 | 0.93 | 
| Region (Europe and America/Asia) | 0.084 | 0.81 | 0.63 | 0.18 | |
| Gender (male/female) | 0.05 | 0.93 | 0.46 | 0.21 | |
| Stage (Ⅰ-Ⅱ/Ⅲ-Ⅳ) | -0.73 | 0.16 | -0.5 | 0.39 | |
| Tumor site (node/rectum) | 0.68 | 0.14 | 0.46 | 0.54 | |
| Degree of differentiation (high/medium/low) | -0.02 | 0.95 | -0.74 | 0.49 | |
- Citation: Liu ZJ, Zhang XW, Liu QQ, Wang SZ. Correlation analysis of interstitial maturity and prognosis of colorectal cancer: Meta-analysis. World J Gastrointest Oncol 2024; 16(6): 2816-2825
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2816.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2816

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        